← All Opportunities

← All Opportunities

Confidential Project

Project Emerald

Late-stage pharmaceutical company advancing Bivante, a DMA-free IV busulfan formulation for stem cell transplant conditioning, on a defined 505(b)(2) regulatory path.

Download Project Emerald ↓

Industry

Pharma / Biotech

Headquarters

Houston, TX

Market

>$300M annual

Capital Sought

$5.0mm Series B

Project Emerald — Investment Teaser Open in New Tab ↗ Download ↓

Loading the teaser… if it does not appear, use “Open in New Tab” or “Download” above.

Strictly confidential

Prepared by Intelligentzia Capital Management

Scroll within the frame to navigate pages

Discuss This Project

Explore Project Emerald

Contact our team to receive additional information under NDA.

Contact Us → All Opportunities

Show more

Show less

Nivel de antigüedad

Sin experiencia

Tipo de empleo

Jornada completa

Función laboral

Otro

Sectores

Servicios financieros